Pharmacy class plaintiffs seeking injunction to implement May Rx pricing suit settlement.
Executive Summary
PHARMACY CLASS PLAINTIFFS TO SEEK TEMPORARY INJUNCTION AT APRIL 16 HEARING before Chicago federal court Judge Charles Kocoras. The retail pharmacy plaintiffs in the consolidated pharmaceutical pricing antitrust case are seeking a court order to implement the non-financial terms of a May 1996 settlement with 11 drug manufacturer defendants, which would require the manufacturers to offer similar rebates to all parties capable of similar influences on market share. The date of the hearing is still tentative; hearings set for April 3 and 10 were postponed because ongoing negotiations had delayed filing of a formal petition to the court.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth